At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Bard Recovery G2 Filter Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Bard® Recovery® Filter Registry (EVEREST) for Patients Who Are Candidates for an Optional (Retrievable) Inferior Vena Cava Filter That Undergo Placement of the Bard® Recovery® Filter.
In Brief
A clinical study evaluating Bard Recovery G2 Filter System for Pulmonary Embolism and Venous Thromboembolic Disease. Completed, enrolled 100 participants.
Detailed Summary
This study was designed to assess the safety of retrieval of the Bard Recovery® G2® Filter System. The G2 filter is an FDA-cleared device for inferior vena caval interruption in patients with pulmonary thromboembolism.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Embolism, Venous Thromboembolic Disease
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 2005
Primary CompletionApr 2007
First PostedNov 2007
TodayJul 2026
First PostedNov 12, 2007
Enrollment StartDec 1, 2005
Primary CompletionApr 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 18.6 years ago
Interventions
Bard Recovery G2 Filter Systemdevice
Retrieval of previously placed RECOVERY G2 IVC filter